Login

DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Fabian Baker from Kingsrose Mining shares insights on his participation in the inaugural BHP Xplor cohort, highlighting the program's impact and experiences.|Mr Fabian Baker is the Managing Director of Kingsrose Mining
00:10:00
Harnessing Real-Time Trends: Revolutionizing Online Bookstore Pricing Strategies |Mikołaj Małaczyński ,CEO , Legimi S.A.
00:10:00
Estate Planning Essentials: Why Early Action Matters
00:10:00
Covington Chair Timothy Hester on Firm's Collaborative Culture | Timothy C. Hester - Partner of Covington & Burling
00:10:00
Duck Creek CEO Mike Jackowski appears on "Squawk Alley" to share insights on the company's outlook following its IPO.|Michael Jackowski, CEO of Duck Creek Technologies,
00:10:00
King Core's Exploration Focus and Strategic Updates Highlighted at One-to-One Mining Conference
00:10:00
Apple's Ecosystem Focus and Antitrust Concerns Amidst iPhone 11 Cycle
00:10:00
leading fund investing in passionate Asian and Pacific Islander entrepreneurs|Bing Chen,Executive Chairman,Gold House Ventures
00:10:00
Unlocking Success: DeeDee Baze & Emily Bissen on Mastering High-Ticket Sales for Women Entrepreneurs | DeeDee Baze - CEO of Alphemita Financial Services
00:10:00
Securing Your Retirement with Highland Financial Planning
00:10:00
AXA IM Research Award 2022: Supporting Professor Ana Queiros' Research in Blue Carbon
00:10:00
Pioneering Excellence: INV Metals' Path to Gold Production

© 2026 Nehu